• Redding, S.W., Rinaldi, M.G., Hicks, J.L.: “The Relationship of Oral Candida Tropicalis Infection to Systemic Candidiasis in a Leukemia Patient”, Special Care in Dentistry, 8(3): 111-114, May-June 1988.

• Redding, S.W., Luce, E.B., Boren, M.W.: “Oral HSV Infection in Patients Receiving Head and Neck Radiation”, Oral Surgery, Oral Medicine, Oral Pathology, 69(5): 578-580, May 1990.

• Redding, S.W., Farinacci, G.C., Smith, J.A., Fothergill, A.W., Rinaldi, M.G.: "A Comparison between Fluconazole Tablets and Clotrimazole Troches for the Treatment of Thrush in HIV Infection", Special Care in Dentistry, 12(1): 24-27, Jan-Feb 1992.

• Pons, V., Greenspan, D., Debruin, M. and the Multicenter Study Group: "Therapy for Oropharyngeal Candidiasis in HIV-Infected Patients: A Randomized, Prospective Multicenter Study of Oral Fluconazole Versus Clotrimazole Troches", J. Acquir. Imm. Def. Synd. 6: 1311-1316, 1993.

• Pfaller, M., Rhine-Chalberg, J., Redding, S., Farinacci, G., Fothergill, A., Rinaldi, M.: “Variations in Fluconazole Susceptibility and Electrophoretic Karyotype among Oral Isolates of Candida albicans from Patients with AIDS and Oral Candidiasis”, J. Clin. Microbiol., 32(1): 59-64, Jan. 1994

• Redding, S., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A., Rhine-Chalberg, J., Pfaller, M.: “Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype Analysis" Clin. Inf. Dis. 18: 240-242, Feb 1994.

• Patterson, T.F., Revankar, S.G., Kirkpatrick, W.R., Dib, O., Fothergill, A.W., Redding, S.W., Sutton, D.A., Rinaldi, M.G.: Simple Method for Detecting Fluconazole-Resistant Yeasts with Chromogenic Agar. J. Clin. Microbiol, 34 (7): 1794-1797, July 1996.

• Glassman, P., Redding, S., Filler, S., Chambers, D.W.: “Program Directors' Opinions on the Competency of Postdoctoral General Dentistry Program Graduates.” J. Dent Educ, 60 (9): 747-754, Sept. 1996.

• Revankar, S.G., Kirkpatrick, W.R., McAtee, R.K., Dib, O.P., Fothergill, A.W., Redding, S.W., Rinaldi, M.G., Patterson, T.F.: “Detection and Significance of Fluconazole Resistance in Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients.” J Infect Dis, 174:821-827, Oct. 1996.

• Zhu, J., Hidalgo, H.A., Holmgreen, W.C., Redding, S.W., Hu, J., Henry, R.J.: “Dental Management of Children with Asthma.” Ped Dent, 18(5) 363-370, 1996.

• White, T.C, Pfaller, M.A., Rinaldi, M.G., Smith, J.A., Redding, S.W.: “Stable Azole Drug Resistance Associated with a Substrain of Candida albicans from an HIV-Infected Patient.” Oral Diseases, 3 (Suppl 1) S102-S109, 1997.

• Redding, S.W., Pfaller, M.A., Messer, S.A., Smith, J.A., Prows, J., Bradley, L.L., Fothergill, A.W., Rinaldi, M.G.: “Variations in Fluconazole Susceptibility and DNA Subtyping of Multiple Candida albicans Colonies from Patients with AIDS and Oral Candidiasis Suffering One or More Episodes of Infection.” J. Clin. Microbiol., 35(7):1761-1765, 1997.

• Revankar, S.G., Dib, O.P., Kirkpatrick, W.R., McAtee R.K., Fothergill, A.W., Rinaldi, M.G., Redding, S.W., Patterson, T.F.: “Clinical Evaluation and Microbiology of Oropharyngeal Infection due to Fluconazole-Resistant Candida in Human Immunodeficiency Virus-Infected Patients.” Clin. Inf. Dis., 26:960-963, 1998.

• Haveman, C.W., Redding, S.W.””Dental Management and Treatment of Xerostomic Patients.” Texas Dental Journal, 115(6):43-56, June 1998.

• Revankar, S.G., Kirkpatrick, W.R., McAtee, R.K., Dib, O.P., Fothergill, A.W., Redding, S.W., Rinaldi, M.G., Hilsenbeck, S.G., Patterson, T.F.: “A Randomized Trial of Continuous or Intermittent Therapy with Fluconazole for Oropharyngeal Candidiasis in HIV Infected Patients: Clinical Outcomes and Development of Fluconazole Resistance.” AM J Med, 105:7-11, 1998.

• Revankar, S.G., Kirkpatrick, W.R., McAtee, R.K., Fothergill, A.W., Redding, S.W., Rinaldi, M.G., Patterson, T.F.: “Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method.” J. Clin. Microbiol., 36(1):153-156, 1998.

• Redding, S.W., Callander, N.S., Haveman, C.W., Leonard, D.L.: “Treatment of Oral Chronic Graft-Versus-Host Disease with PUVA Therapy-Case Report and Review of Literature.” Oral Surg Oral Med Oral Pathol, 86(2):183-187, 1998.

• Redding, S.W., Zellars, R.C., Kirkpatrick, W.R., McAtee, R.K., Caceres, M.A., Fothergill, A.W.,Lopez-Ribot, J.L., Bailey, C.W.,Rinaldi, M.G., Patterson, T.F.: “Epidemiology of Oropharyngeal Candida Colonization and Infection in Patients Receiving Radiation for Head and Neck Cancer.” J. Clin. Microbiol., 37(12): 3896-3900, 1999.

• Redding, S.W., Kirkpatrick, W.R., Dib, O., Fothergill, A.W., Rinaldi, M.G., Patterson, T.F.: “The Epidemiology of Non-Albicans Candida in Oropharyngeal Candidiasisin HIV Patients”, Spec. Care Dent., 20(5): 178-181, 2000.

• Redding, S.W., Bailey, C.W., Lopez-Ribot, J.L., Kirkpatrick, W.R., Fothergill, A.W., Rinaldi, M.G., Patterson, T.F.: Candida dubliniensis in Radiation Induced Oropharyngeal Candidiasis”, Oral Surg Oral Med Oral Path Oral Radiol endod. 91: 659-662, 2001.

• Redding , S.W.: “The Role of Yeasts other than Candida albicans in Oropharyngeal Candidiasis”, Cur. Opin. Inf. Dis. 14:673-677, 2001.

• Redding , S.W., Kirkpatrick W.R., Coco B.J., Sadkowski L., Fothergill A. W., Rinaldi M.G., et al. “Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer”. Journal of Clinical Microbiology 2002;40(5):1879-1881.

• Redding SW, Kirkpatrick WR, Saville S, Coco BJ, White WS, Fothergill AW, Rinaldi MG, Eng T, Patterson TF, LopezRibot J: “Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with OropharyngealCandidiasis Receiving Head and Neck Radiation” J Clin Microbiol, 41(2): 619-622, 2003.

• Harrison JS, Dale RA, Haveman CW, Redding SW: “Oral Compl;ications in Radiation Therapy.” Gen Dent, 51(6): 552 560, 2003.

• Redding SW: “Clinical Laboratory Tests.” Endodontic Topics, 4: 22-31. 2003.

• Dahiya MC, Redding SW, Dahiya RS, Eng TY, Kirkpatrick WR, Coco BJ, Sadkowski LC, Fothergill AW, Waite A, Rinaldi MG, Patterson TF, Thomas CR: “Oropharyngeal Candidiasis Caused by Non-albicans Yeast in Patients Receiving External Beam Radiotherapy for Head-and-Neck Cancer.” Int J Radiation Oncology Biol. Phys ., 57(1): 79-83, 2003.

• Porteous NB, Grooters AM, Redding SW, Thompson EH, Rinaldi MG, De Hoog GS, Sutton DA: “Identification of Exophiala mesophila Isolated from Treated Dental Unit Waterlines.” J Clin Microbiol , 41(8): 3885-3889, 2003.

• Porteous NB, Redding SW, Thompson EH, Grooters AM, De Hoog GS, Sutton DA: “Isolation of an Unusual Fungus in Treated Dental Unit Water Lines.” JADA, 134: 853-858, 2003.

• Redding SW: “Oral Complications of Cancer Therapy” Texas Medicine, 99(5): 54-57, 2003.

• Meropol MJ, Somer RA, Gutheil J, Pelley RJ, Modiano MR, Rowinsky EK, Rothenberg ML, Redding SW, Serdar CM, Yao B, Heard R, Rosen LS. “Randomized Phase I Trail of Recombinant Human Keratinocyte Growth Factor Plus chemotherapy: Potential Role as Mucosal Protectant.” J Clin Oncol, 21(8): 1452-1458, 2003.

• Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, Rinaldi MG, Thomas CR: “Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.” Oral Surg Oral Med Oral Pathol Oral Radiol, 97(1): 47-52, 2004.

Previous Grant Support:

Ongoing Research Support

• McNeil, Inc. 2003-2004
  • A Double Blind Randomized Vehicle Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% in Subjects with Radiation Induced Oral Mucositis
  • The goal of this study is to evaluate the ability of benzydamine hydrochloride to reduce radiation induced oral mucositis.
  • Role: PI
• RO1-DE11381-05 Patterson (PI) 2000-2004
  • NIH/NIDCR
  • Fluconazole Resistance in Oropharyngeal Candidiasis Renewal
  • The goal of this study is to evaluate the molecular mechanisms involved in the development of fluconazole resistance in patients with oropharyngeal candidiasis.
  • Role: co-investigator

Completed Research Support

Molecular Characterization of Oropharyngeal Candida Colonization and Infection in Patients Receiving Pre-emptive Fluconazole Therapy to Manage Oropharyngeal Candidiasis Secondary to Radiation for Head and Neck Cancer

The goal of this study was to track the epidemiology of oral Candida in head and neck radiation patients receiving long term fluconazole therapy.

Role: PI